Search Results - "Terán, Luis M."

Refine Results
  1. 1
  2. 2
  3. 3

    Antimicrobial peptides: General overview and clinical implications in human health and disease by Guaní-Guerra, Eduardo, Santos-Mendoza, Teresa, Lugo-Reyes, Saúl O, Terán, Luis M

    Published in Clinical immunology (Orlando, Fla.) (01-04-2010)
    “…Abstract Antimicrobial peptides (AMPs) are evolutionarily conserved molecules involved in the defense mechanisms of a wide range of organisms. Produced in…”
    Get full text
    Journal Article
  4. 4

    Oxidative Stress and Air Pollution: Its Impact on Chronic Respiratory Diseases by Sierra-Vargas, Martha Patricia, Montero-Vargas, Josaphat Miguel, Debray-García, Yazmín, Vizuet-de-Rueda, Juan Carlos, Loaeza-Román, Alejandra, Terán, Luis M

    “…Redox regulation participates in the control of various aspects of metabolism. Reactive oxygen and nitrogen species participate in many reactions under…”
    Get full text
    Journal Article
  5. 5

    Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy by Galván Morales, Miguel Angel, Barrera Rodríguez, Raúl, Santiago Cruz, Julio Raúl, Teran, Luis M

    Published in Molecules (Basel, Switzerland) (02-12-2020)
    “…According to data from the U.S. National Cancer Institute, cancer is one of the leading causes of death worldwide with approximately 14 million new cases and…”
    Get full text
    Journal Article
  6. 6

    Neuroimmune Pathophysiology in Asthma by Pavón-Romero, Gandhi F., Serrano-Pérez, Nancy Haydée, García-Sánchez, Lizbeth, Ramírez-Jiménez, Fernando, Terán, Luis M.

    “…Asthma is a chronic inflammation of lower airway disease, characterized by bronchial hyperresponsiveness. Type I hypersensitivity underlies all atopic diseases…”
    Get full text
    Journal Article
  7. 7

    New Insights into the Role of PD-1 and Its Ligands in Allergic Disease by Galván Morales, Miguel Angel, Montero-Vargas, Josaphat Miguel, Vizuet-de-Rueda, Juan Carlos, Teran, Luis M

    “…Programmed cell death 1 (PD-1) and its ligands PD-L1 and PD-L2 are receptors that act in co-stimulatory and coinhibitory immune responses. Signaling the…”
    Get full text
    Journal Article
  8. 8

    Current Insights on the Impact of Proteomics in Respiratory Allergies by Vizuet-de-Rueda, Juan Carlos, Montero-Vargas, Josaphat Miguel, Galván-Morales, Miguel Ángel, Porras-Gutiérrez-de-Velasco, Raúl, Teran, Luis M

    “…Respiratory allergies affect humans worldwide, causing extensive morbidity and mortality. They include allergic rhinitis (AR), asthma, pollen food allergy…”
    Get full text
    Journal Article
  9. 9

    Allergen Immunotherapy: Current and Future Trends by Pavón-Romero, Gandhi F, Parra-Vargas, Maria Itzel, Ramírez-Jiménez, Fernando, Melgoza-Ruiz, Esmeralda, Serrano-Pérez, Nancy H, Teran, Luis M

    Published in Cells (Basel, Switzerland) (08-01-2022)
    “…Allergen immunotherapy (AIT) is the sole disease-modifying treatment for allergic rhinitis; it prevents rhinitis from progressing to asthma and lowers…”
    Get full text
    Journal Article
  10. 10

    Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future by Ramírez-Jiménez, Fernando, Pavón-Romero, Gandhi Fernando, Velásquez-Rodríguez, Juancarlos Manuel, López-Garza, Mariana Itzel, Lazarini-Ruiz, José Fernando, Gutiérrez-Quiroz, Katia Vanessa, Teran, Luis M

    Published in Pharmaceuticals (Basel, Switzerland) (01-02-2023)
    “…The discovery of the mechanism underlying allergic disease, mouse models of asthma, and bronchoscopy studies provided initial insights into the role of…”
    Get full text
    Journal Article
  11. 11

    Ligustrum pollen: New insights into allergic disease by Robledo-Retana, Tania, Mani, Blessy M., Teran, Luis M.

    Published in The World Allergy Organization journal (01-02-2020)
    “…Respiratory allergies are important medical conditions because they affect nearly 20% of the population worldwide, with higher prevalence in industrialized…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Biochemical pathogenesis of aspirin exacerbated respiratory disease (AERD) by Narayanankutty, Arun, Reséndiz-Hernández, Juan Manuel, Falfán-Valencia, Ramcés, Teran, Luis M.

    Published in Clinical biochemistry (01-05-2013)
    “…Aspirin exacerbated respiratory disease (AERD) is a distinct clinical entity characterized by eosinophilic rhinosinusitis, asthma and often nasal polyposis…”
    Get full text
    Journal Article
  14. 14

    Physiopathology and genetics in aspirin-exacerbated respiratory disease by Pavón-Romero, Gandhi F., Ramírez-Jiménez, Fernando, Roldán-Alvarez, Marco Alejandro, Terán, Luis M., Falfán-Valencia, Ramcés

    Published in Experimental lung research (14-09-2017)
    “…Introduction: Aspirin-exacerbated respiratory disease (AERD) is a clinical entity characterized by hypersensitivity to aspirin leading to asthma and chronic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Human Neutrophil Defensin-1, -3, and -4 Are Elevated in Nasal Aspirates from Children with Naturally Occurring Adenovirus Infection by Teran, Luis M., Lara-Padilla, Eleazar, Zarate-Segura, Paola, Santiago-Cruz, J., Renteria-Rosales, C., Molina-Macip, M., Ramírez-Jiménez, F., Priyadharshini, V. S.

    Published in Canadian respiratory journal (01-01-2018)
    “…Background. Adenoviruses are highly contagious pathogens which cause respiratory disease particularly in children; they may induce severe disease in infants…”
    Get full text
    Journal Article
  18. 18

    Human β-Defensin-2 Induction in Nasal Mucosa after Administration of Bacterial Lysates by Guaní-Guerra, Eduardo, Negrete-García, María Cristina, Montes-Vizuet, Rosalía, Asbun-Bojalil, Juan, Terán, Luis M

    Published in Archives of medical research (01-04-2011)
    “…Background and Aims The airway epithelium produces antimicrobial peptides (AMPs) that prevent colonization of host tissues by a wide range of pathogens. Human…”
    Get full text
    Journal Article
  19. 19
  20. 20